» Articles » PMID: 32519746

Gut Dysbiosis is Associated with Primary Hypothyroidism with Interaction on Gut-thyroid Axis

Overview
Journal Clin Sci (Lond)
Date 2020 Jun 11
PMID 32519746
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Background Previous studies have shown that the gut microbiome is associated with thyroid diseases, including Graves' disease, Hashimoto's disease, thyroid nodules, and thyroid cancer. However, the association between intestinal flora and primary hypothyroidism remains elusive. We aimed to characterize gut microbiome in primary hypothyroidism patients. Methods Fifty-two primary hypothyroidism patients and 40 healthy controls were recruited. The differences in gut microbiota between the two groups were analyzed by 16S rRNA sequencing technology. Fecal microbiota transplantation (FMT) was performed in mice using flora from both groups; changes in thyroid function were then assessed in the mice. Results There were significant differences in α and β diversities of gut microbiota between primary hypothyroidism patients and healthy individuals. The random forest analysis indicated that four intestinal bacteria (Veillonella, Paraprevotella, Neisseria, and Rheinheimera) could distinguish untreated primary hypothyroidism patients from healthy individuals with the highest accuracy; this was confirmed by receiver operator characteristic curve analysis. The short chain fatty acid producing ability of the primary hypothyroidism patients' gut was significantly decreased, which resulted in the increased serum lipopolysaccharide (LPS) levels. The FMT showed that mice receiving the transplant from primary hypothyroidism patients displayed decreased total thyroxine levels. Conclusions Our study suggests that primary hypothyroidism causes changes in gut microbiome. In turn, an altered flora can affect thyroid function in mice. These findings could help understand the development of primary hypothyroidism and might be further used to develop potential probiotics to facilitate the adjuvant treatment of this disease.

Citing Articles

The influence of Lactobacillus johnsonii on tumor growth and lymph node metastasis in papillary thyroid carcinoma.

Xie M, Yang T, Liu Q, Ning Z, Feng L, Min X Commun Biol. 2025; 8(1):419.

PMID: 40074848 PMC: 11903660. DOI: 10.1038/s42003-025-07856-9.


Gut microbiota alteration was related to subclinical hypothyroidism and dyslipidemia in mice.

Wang R, Yu X, Cai H, Lu G, Gao D, Zhang M FASEB J. 2025; 39(5):e70445.

PMID: 40052844 PMC: 11887603. DOI: 10.1096/fj.202402289RR.


Recent advances in gut microbiota and thyroid disease: pathogenesis and therapeutics in autoimmune, neoplastic, and nodular conditions.

Fang L, Ning J Front Cell Infect Microbiol. 2025; 14():1465928.

PMID: 39776440 PMC: 11703873. DOI: 10.3389/fcimb.2024.1465928.


Application of Mendelian randomization in thyroid diseases: a review.

Li Z, Wang R, Liu L, Jia Z, Zhou P, He Q Front Endocrinol (Lausanne). 2025; 15:1472009.

PMID: 39749022 PMC: 11693456. DOI: 10.3389/fendo.2024.1472009.


Impact of Probiotics and Prebiotics on Gut Microbiome and Hormonal Regulation.

Basnet J, Eissa M, Yanes Cardozo L, Romero D, Rezq S Gastrointest Disord (Basel). 2024; 6(4):801-815.

PMID: 39649015 PMC: 11623347. DOI: 10.3390/gidisord6040056.